The odds that a patient visiting the emergency department is diagnosed with cannabis use disorder (CUD) is nearly 50 percent lower in states that have legalized...
The National Institutes of Health (NIH) is soliciting proposals to develop psychedelics into treatments for substance use disorder (SUD), with plans to issue $2 million in...
For nearly as long as the federal government has classified marijuana as a Schedule I controlled substance, the Food and Drug Administration (FDA) has been evaluating...
A new report looking into how CBD access affects opioid prescriptions concludes that while legalizing CBD may not itself reduce opioid prescribing rates, the ability to...
The federal health agency is awarding researchers $3.2 million to study the effects of using cannabis while receiving immunotherapy for cancer treatment, as well as whether...
States that legalized marijuana in 2016 saw meaningful declines in traffic fatalities during the years immediately following the policy change, according to a new study by...
While many marijuana enthusiasts believe that components called terpenes are responsible for strains’ distinctive smells, a new study published by the American Chemical Society has identified...
A newly published study finds that people who practice yoga after consuming marijuana experience improved mindfulness and mysticality, indicating that setting and behavior may play an...
A new study into the therapeutic effects of psilocybin suggests that use of the psychedelic drug can help ease psychological distress in people who had adverse...
Cannabis consumers who caught COVID-19 had significantly lower rates of intubation, respiratory failure and death than people who do not use marijuana, according a new study...